Latest Pradaxa news
Dabigatran May Be Better Than Warfarin After Bleeding Episode
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Dabigatran is less likely than warfarin to cause recurrent bleeding in atrial fibrillation patients who have experienced a major bleeding event, according to a study published online Dec. 1 in Stroke.
Higher Bleeding Risk Seen With Rivaroxaban Versus Dabigatran
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rivaroxaban may pose a slightly greater risk of serious bleeding than dabigatran in patients with atrial fibrillation, according to a study published online Oct. 3 in JAMA Internal Medicine.
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum 
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk 
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
2011 to 2021 Saw Heart Failure-Related Hospitalization Rise in CKD 
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes Monthly Specialist Briefings
Stay Connected
